Akebia Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Akebia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Akebia Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Akebia Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $423 | 231 | 1.83 |
| 2023-12-31 | $286 | 231 | 1.24 |
| 2023-09-30 | $108k | 95k | 1.14 |
| 2023-06-30 | $35k | 38k | 0.92 |
| 2023-03-31 | $45k | 82k | 0.55 |
| 2022-12-31 | $2.0k | 4.0k | 0.49 |
| 2022-06-30 | $3.0k | 7.2k | 0.42 |
| 2022-03-31 | $3.1M | 4.3M | 0.73 |
| 2021-12-31 | $10M | 4.4M | 2.26 |
| 2021-03-31 | $4.1M | 1.2M | 3.38 |
| 2020-12-31 | $4.1M | 1.5M | 2.80 |
| 2020-09-30 | $0 | 228k | 0.00 |
| 2020-06-30 | $3.1M | 234k | 13.39 |
| 2020-03-31 | $3.6M | 480k | 7.58 |
| 2019-12-31 | $1.8M | 287k | 6.32 |
| 2019-09-30 | $1.2M | 307k | 3.92 |
| 2019-06-30 | $1.4M | 295k | 4.63 |
| 2019-03-31 | $2.3M | 280k | 8.19 |
| 2018-12-31 | $1.6M | 281k | 5.53 |
| 2018-09-30 | $2.7M | 306k | 8.82 |
| 2018-06-30 | $3.0M | 297k | 9.97 |
| 2018-03-31 | $2.6M | 272k | 9.53 |
| 2017-12-31 | $4.3M | 286k | 14.87 |
| 2017-03-31 | $117k | 13k | 9.24 |
| 2016-12-31 | $576k | 55k | 10.40 |
| 2016-06-30 | $10k | 1.3k | 7.74 |
| 2016-03-31 | $5.0k | 504 | 9.92 |
| 2015-12-31 | $2.0k | 135 | 14.81 |